TBG096

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funder: National Key Research and Development Program of China

Animals1

Outcomes

Dihydrotestosterone

downin mice1

1 study

TBG096 decreases dihydrotestosterone in mice.
“TBG096 also reduced DHT levels, increased keratin 15 (k15) expression and regulated growth factors like IGF-1 and epidermal growth factor (EGF)”
Animals
TBG096 stimulates hair regeneration through IGF-1R-mediated angiogenesis
Biochemical pharmacology29 Jan 2026

Latest

1 in 12 months

Biochemical Pharmacology1 Feb

TBG096 stimulates hair regeneration through IGF-1R-mediated angiogenesis

Experiments in miceInterventions

Paper

TBG096

Outcomes

Latest

TBG096 stimulates hair regeneration through IGF-1R-mediated angiogenesis

Related